Skip to content

Dermatologic Avatar LLM-based Anamnesis Study

Dermatologic Avatar LLM-based Anamnesis Study - DALLAS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039452
Enrollment
170
Registered
2026-02-26
Start date
2026-05-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne inversa (Hidradenitis suppurativa) Basal cell carcinoma Variable diseases in walk-in patients

Interventions

Group 1: Study arm 1 – Pre-hospitalization cases • Subgroup 1-AI – Prospective
Anamnesis with AI avatar support: 40 patients (20 basal cell carcinoma, 20 acne inversa) • Subgroup 1-RE – Retrospective
Anamnesis without AI avatar support: 40 patients (20 basal cell carcinoma, 20 acne inversa) Total: 80 pre-hospitalization cases Group 2: Study arm 2 – Walk-in outpatient cases • Subgroup 2-AI – Prospe
Anamnesis with AI avatar support: 40 patients • Subgroup 2-RE – Retrospective
Anamnesis without AI avatar support: 40 patients Total: 80 walk-in outpatient cases

Sponsors

Department of Dermatology, Venerology and Allergology - University of Leipzig Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who present at the Clinic and Polyclinic for Dermatology, Venereology, and Allergology at ?University of Leipzig Medical Center for pre-admission due to basal cell carcinoma or acne inversa, or as unplanned walk-in patients without an appointment. Employees: Physicians, nurses, and employees of ?University of Leipzig Medical Center who are or were involved in the pre-admission or care of unplanned walk-ins in relation to the above-mentioned patients and/or are expected to contribute to the quality assessment, AI tool evaluation, and assessment of usage circumstances.

Exclusion criteria

Exclusion criteria: Persons under the age of 18, persons incapable of giving consent, non-German-speaking persons, pregnant and breastfeeding persons, as well as persons who are or were unable to undergo the anamnesis process – with or without an AI tool – due to cognitive or physical illnesses are excluded.

Design outcomes

Primary

MeasureTime frame
Project objectives: Primary project objective: Observational investigation of an AI-supported avatar developed and used in patient care to assist with dermatological anamnesis. Secondary project objectives: Evaluation of the quality, functionality, time savings, and acceptance of AI-supported anamnesis compared to conventional anamnesis. The quality of documentation is analyzed using a structured evaluation matrix developed specifically for the study (0–4 points per criterion). In addition, the time required for the medical history and the estimated time savings are recorded. Acceptance and user experience are assessed using standardized questions/questionnaires, including the User Experience Questionnaire – Short Version (UEQ-S), the TAEG questionnaire (short version), and the AIAS-4 – AI Attitude Scale. In addition, the circumstances of use of the AI tool are documented.

Secondary

MeasureTime frame
see project objectives above.

Countries

Germany

Contacts

Public ContactFelix von Krogh

Universitätsklinikum Leipzig - Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie

Felix.Krogh@medizin.uni-leipzig.de+49 341 97 18600

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026